Clinical Trials on Chondrosarcoma, Mesenchymal

Total 159 results

Centre Antoine Lacassagne

Recruiting

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy (P1V2)

Osteosarcoma | Ewing Sarcoma | Chondrosarcoma | Chordoma

France
Infinity Pharmaceuticals, Inc.

Completed

IPI-926 Extension Protocol for Continuation of Treatment With IPI-926

Chondrosarcoma | Basal Cell Carcinoma

United States
Sarcoma Alliance for Research through Collaboration

Completed

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Sarcoma
Samsung Medical Center

Active, not recruiting

Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

Intracranial Hemorrhages | Mesenchymal Stem Cells | Newborn Infant

Korea, Republic of
Istituto Ortopedico Rizzoli

Recruiting

Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery (ADER)

Osteosarcoma | Ewing Sarcoma | Chondrosarcoma | Bone Tumor

Italy
Ahmad Jabir Rahyussalim

Unknown

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

Mesenchymal Stem Cell | Spinal Tuberculosis

Indonesia
The Affiliated Hospital of Xuzhou Medical University

Unknown

Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells

Chronic Kidney Diseases | Mesenchymal Stem Cells | Renal Interstitial Fibrosis

China
Stemedica Cell Technologies, Inc.
CardioCell LLC

Withdrawn

A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

ST Segment Elevation Myocardial Infarction (STEMI) | Allogeneic Mesenchymal Bone Marrow Cells

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Metformin And Chloroquine in IDH1/2-mutated Solid Tumors (MACIST)

Glioma | Cholangiocarcinoma | Chondrosarcoma

Netherlands
Forma Therapeutics, Inc.

Completed

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) | Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) | Cohort 3a and 3b: Chondrosarcoma | Cohort 4a and 4b: Intrahepatic... and other conditions

United States, Korea, Republic of, Australia, United Kingdom, Spain, France
Institut de Recherches Internationales Servier

Completed

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

Glioma | Cholangiocarcinoma | Chondrosarcoma | Other Advanced Solid Tumors

United States, France
Maastricht University Medical Center

Not yet recruiting

Muscle Stem Cell Quality in Atrophy (ATROMAB)

Muscle Weakness | Stem Cell Transplantation | Sarcopenia | Cachexia | Mesenchymal Stem Cells | Atrophy, Muscle
Shanghai East Hospital
Sir Run Run Shaw Hospital

Recruiting

UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia

COVID-19 Pneumonia | Mesenchymal Stem Cell

China
Hospital San Vicente Fundación
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaborators

Not yet recruiting

Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix (scorem-cells)

Cardiovascular Diseases | Coronary Artery Disease | Heart Failure | Regenerative Medicine | Mesenchymal Stem Cell Transplantation

Colombia
Sun Yat-sen University

Completed

Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation

Liver Failure | Mesenchymal Stem Cells

China
Institute of Hematology & Blood Diseases Hospital

Active, not recruiting

Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

Thrombocytopenia | Mesenchymal Stem Cells

China
Mayo Clinic

Recruiting

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

Ewing Sarcoma of Bone | Chondrosarcoma | Chordoma | Bone Sarcoma | Pelvic Rhabdomyosarcoma

United States
Cell2Cure ApS

Recruiting

ASC - Autism Study

Inflammatory Bowel Diseases | Autism Spectrum Disorder | Gastrointestinal Dysfunction | Mesenchymal Stromal Cells | Leaky Gut Syndrome

Denmark
Karolinska Institutet

Completed

Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden

Multiple Sclerosis | Autologous Mesenchymal Stem Cells

Sweden
Fred Hutchinson Cancer Center
Incyte Corporation

Active, not recruiting

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Refractory Soft Tissue Sarcoma | Metastatic Leiomyosarcoma | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Advanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Advanced Synovial Sarcoma | Metastatic Chondrosarcoma | Advanced Leiomyosarcoma | Metastatic Myxoid... and other conditions

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

Osteosarcoma | Chondrosarcoma | Bone Neoplasm | Bone Sarcoma | Ewing's Sarcoma | Osseous Sarcoma

United States
Eli Lilly and Company
Loxo Oncology, Inc.

Active, not recruiting

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Glioma | Cholangiocarcinoma | Chondrosarcoma | Any Solid Tumor

United States, Spain, Korea, Republic of, Australia, Japan, Taiwan, France, Singapore, Hong Kong
National Cancer Institute (NCI)

Recruiting

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Locally Advanced Chondrosarcoma | Metastatic Chondrosarcoma | Metastatic Sinonasal Adenocarcinoma | Locally Advanced Sinonasal Adenocarcinoma | Metastatic Large-cell Neuroendocrine Carcinoma | Locally Advanced Large-cell Neuroendocrine Carcinoma | Metastatic Olfactory Neuroblastoma | Locally Advanced... and other conditions

United States
Leiden University Medical Center
HollandPTC; Varian Medical Systems

Recruiting

Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas (CHIPT)

Magnetic Resonance Imaging | Chondrosarcoma | Chordoma | Proton Therapy | Bone Neoplasm of Vertebral Column | PET-CT

Netherlands
Southwest Hospital, China
Xinqiao Hospital of Chongqing

Recruiting

Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing

Mesenchymal Stem Cells

China
The Republican Research and Practical Center for...
The Republican Center for Research and Practice in Otolaryngology; Belarusian...

Completed

Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

Mesenchymal Stem Cells | Tracheal Stenosis | Laryngeal Stenosis

Belarus
Peking Union Medical College Hospital

Unknown

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

Oncogenic Osteomalacia | Mesenchymal Tumor

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)

Mesenchymal Stem Cells | Sjogren's Syndrome

China
Tehran University of Medical Sciences

Completed

Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Mesenchymal Stem Cells | Secondary-Progressive Multiple Sclerosis

Iran, Islamic Republic of
University of Miami

Temporarily not available

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND) (EXPAND)

Stroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain Attack

United States
Centre Leon Berard

Recruiting

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (REGOSTA)

Osteosarcoma | Ewing Sarcoma | Chondrosarcoma | Leiomyosarcoma | Angiosarcoma | Bone Sarcoma | Undifferentiated Pleomorphic Sarcoma

France
Qingdao University

Unknown

Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot

Diabetic Foot | Mesenchymal Stem Cells | Critical Limb Ischemia | Umbilical Cord

China
Cell2Cure ApS

Recruiting

Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. (STEMFOOT)

Diabetic Foot Ulcer | Mesenchymal Stromal Cells

Denmark
Ricoh USA, Inc.

Recruiting

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Osteosarcoma | Sarcoma, Ewing | Chondrosarcoma | Fibrosarcoma | Fibrous Histiocytoma

United States
Heike E Daldrup-Link

Completed

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI (Osteosarcoma)

Bone Cancer | Osteosarcoma | Chondrosarcoma | Rhabdomyosarcoma | Bone Sarcoma | Osteomyelitis | Bone Necrosis | Ewing's Sarcoma

United States
Mercy Research

Completed

Stereotactic Body Radiotherapy for Head and Neck Tumors

Nasopharyngeal Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Salivary Gland Cancer | Paraganglioma of Head and Neck | Head and Neck Sarcoma | Chordoma of Head and Neck | Chondrosarcoma of Head and Neck | Angiofibroma of Head and Neck

United States
Icahn School of Medicine at Mount Sinai
National Heart, Lung, and Blood Institute (NHLBI); Mesoblast, Inc.

Terminated

MSCs in COVID-19 ARDS

COVID | Acute Respiratory Distress Syndrome | Mesenchymal Stromal Cells | Remestemcel-L

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

LYell SYndrome MEsenchymal Stromal Cells Treatment (LYSYME)

Mesenchymal Stromal Cells | Lyell Syndrome | Overlap Syndrome | Toxic Epidermal Necrolysis | Epidermal Necrolysis | Adipose Derived Stromal Cells
IGM Biosciences, Inc.

Recruiting

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers

Sarcoma | Acute Myeloid Leukemia | Colorectal Cancer | Solid Tumor | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chondrosarcoma | Small Lymphocytic Lymphoma

United States, Korea, Republic of, France, Spain, Australia
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Terminated

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Chondrosarcoma | Adult Rhabdomyosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma | Adult Malignant Meningioma | Adult Brain Malignant Hemangiopericytoma

United States, Australia, Peru, Puerto Rico
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell Carcinoma | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

United States
Celgene
Celgene Corporation

Completed

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

Glioma | Solid Tumor | Angioimmunoblastic T-cell Lymphoma | Chondrosarcoma | Intrahepatic Cholangiocarcinoma

United States, France
National Cancer Institute (NCI)

Completed

Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

Chondrosarcoma | Gastrointestinal Stromal Tumor | Paraganglioma | Carney Complex

United States
Assaf-Harofeh Medical Center

Unknown

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Soft Tissue Sarcoma | Osteosarcoma | Chondrosarcoma | Bone Sarcoma | Desmoplastic Small Round Cell Tumor | Gastrointestinal Stromal Sarcoma | Ewing's Tumor Metastatic | Ewing's Tumor Recurrent
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage I Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Dermatofibrosarcoma Protuberans | Adult Angiosarcoma | Adult Epithelioid Sarcoma | Adult Extraskeletal Osteosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma and other conditions

United States, Canada, Australia, New Zealand, Puerto Rico
OHSU Knight Cancer Institute
Novartis Pharmaceuticals; Oregon Health and Science University

Completed

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Adult Alveolar Soft Part Sarcoma | Adult Angiosarcoma | Adult Desmoplastic Small Round Cell Tumor | Adult Epithelioid Hemangioendothelioma | Adult Epithelioid Sarcoma | Adult Extraskeletal Myxoid Chondrosarcoma | Adult Extraskeletal... and other conditions

United States
Inhibrx, Inc.

Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Sarcoma | Pancreatic Adenocarcinoma | Ewing Sarcoma | Gastric Adenocarcinoma | Chondrosarcoma | Solid Tumors | Malignant Pleural Mesothelioma | Colorectal Adenocarcinoma | GIST | SDH-deficient Solid Tumors

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

Bone Cancer | Chondrosarcoma | Recurrent Osteosarcoma | Clear Cell Sarcoma of the Kidney | Metastatic Osteosarcoma | Ovarian Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Uterine Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage III Uterine Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage...

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Iovance Biotherapeutics, Inc.

Active, not recruiting

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Malignant Solid Neoplasm | Soft Tissue Sarcoma | Recurrent Ovarian Carcinoma | Triple Negative Breast Cancer | Recurrent Osteosarcoma | Refractory Osteosarcoma | Bone Sarcoma | Giant Cell Tumor of Bone | Ovarian Carcinosarcoma | Platinum-Resistant Ovarian Carcinoma | Dedifferentiated Chondrosarcoma | Malignancy... and other conditions

United States
National Cancer Institute (NCI)

Completed

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Gastrointestinal Stromal Tumor | Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Adult Rhabdomyosarcoma | Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal... and other conditions

Clinical Trials on Chondrosarcoma, Mesenchymal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations